Present status of adjuvant chemotherapy for elderly breast cancer patients. - sprookjes - yvandenbroek - TriplyDB

Present status of adjuvant chemotherapy for elderly breast cancer patients.

Present status of adjuvant chemotherapy for elderly breast cancer patients.

http://www.wikidata.org/entity/Q37677693

about

Age Does not Matter, Biology of Both Cancer and Patient Does.Chemotherapy in Old Women with Breast Cancer: Is Age Still a Predictor for Under Treatment?

P2860

Q37677751-C95C4397-CF67-4DDD-BAAB-ED1AF624425A Q48034006-7EEDBBFC-8ABE-48DF-99E3-C9E940A8B40B

P2860

Present status of adjuvant chemotherapy for elderly breast cancer patients.

http://www.wikidata.org/entity/Q37677693

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Present status of adjuvant chemotherapy for elderly breast cancer patients.

@en

Present status of adjuvant chemotherapy for elderly breast cancer patients.

@nl

type

label

Present status of adjuvant chemotherapy for elderly breast cancer patients.

@en

Present status of adjuvant chemotherapy for elderly breast cancer patients.

@nl

prefLabel

Present status of adjuvant chemotherapy for elderly breast cancer patients.

@en

Present status of adjuvant chemotherapy for elderly breast cancer patients.

@nl

P1433

Q37677693-85846C42-46C7-4FEA-B66E-FC720E46C7BA

P1476

Q37677693-6C0E8409-F0EF-4FE7-A29B-365181C507D4

P2860

Q37677693-01E9A9DC-E3C7-4434-9430-55035DD2DD37

Q37677693-033E60F2-4DEA-46D0-BB09-DFA68BE66BED

Q37677693-0BAB6D68-02ED-40F0-97D8-8545896F9983

Q37677693-106EE8AB-0DE4-41EE-B866-FF6D4996FA16

Q37677693-1C142FB1-EB6B-4FCF-8F73-ADF70899BB14

Q37677693-1C76A539-00CF-4A81-9B5B-72B01348BA76

Q37677693-21C2F418-DB19-40B8-865D-D64063EA99CB

Q37677693-27830FD9-3E6D-4D94-9E6F-5ED89CDA9650

Q37677693-2B988775-D1BF-4548-9C66-B786D2855706

Q37677693-30962FE8-55FD-4839-BEB1-88025E75886C

P304

Q37677693-C38B2AC5-1F68-457B-9B69-E7F8CC45C4D0

P31

Q37677693-9552BC4C-5373-4AC9-9B63-E642E51F6ECB

P356

Q37677693-1CD4C2EB-8758-491D-B6A2-45132DD544BC

P433

Q37677693-908491B8-27D4-4698-B705-305AB9C0CA84

P478

Q37677693-9231F505-8467-4ACD-A267-C420205C4505

P50

Q37677693-3DC8623B-AE80-4A05-9204-76F2C0185EE9

Q37677693-C2F6BA02-4198-44CA-B93A-F50ED9D9FB61

P577

Q37677693-E3473EAC-530E-4BC5-A515-0539CA02451B

P698

Q37677693-810EFCFA-3FC2-4574-A592-4293CDF06C4F

P921

Q37677693-4289083D-E864-428C-AC0D-06088930E1EB

P932

Q37677693-1B5481F4-3295-45A2-A25A-AB7F4D8725B5

P356

P1433

P1476

Present status of adjuvant chemotherapy for elderly breast cancer patients.

@en

P2860

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population.

Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: safety data from the multicentre phase 3 randomised ELDA trial.

Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer

Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study.

Up-to-date estimates of breast cancer survival for the years 2000-2004 in 11 European countries: the role of screening and a comparison with data from the United States.

Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians.

Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.

P304

439-444

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000345867

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Mattea Reinisch

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24715824

http://www.w3.org/2001/XMLSchema#string

P921

P932

3971796

http://www.w3.org/2001/XMLSchema#string